Main Article Content
Evaluation of tumour markers was done in 242 patients of various malignancies at different stages and phases of treatment. The evaluation was done in randomly selected cases. Five tumour markers were evaluated namely, Carcinoembryonic Antigens (CEA), Alpha Feto Protein (AFP), CA 125, Prostatic Acid Phosphate (PAP) and Human Chorionic Gonadotrophin (HCG). Titres of PAP were raised in patients with carcinoma of prostate while all other tunours markers showed varied positive results ranging from varied with other tumours marker I different malignancies.
Work published in JPMI is licensed under a
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.